Management of Arrhythmic Mitral Valve Prolapse: Potential Impact and Current Evidence

Mitral valve prolapse (MVP), also known as floppy mitral valve syndrome, systolic click-murmur syndrome, and billowing mitral leaflets, is a developmental anomaly caused when one or two abnormal valve leaflets are displaced into the left atrium below the mitral valve annulus during systole. MVP is observed in 2-3% of patients in the general population and is the leading cause of mitral regurgitation (MR) in developed countries. Overall, MVP is considered a benign developmental anomaly; however, evidence suggests that MVP is associated with sudden cardiac death. Thus, there have been ongoing discussions about the optimal management of this patient group, which includes both pharmacological treatment and surgical interventions. This review aimed to provide an overview of the benign and arrhythmic MVP (AMVP), its diagnostic options, and management possibilities.

Authors

Institutions

Publication Details

Journal
Reviews in Cardiovascular Medicine
Published
2025-09-19
DOI
https://doi.org/10.31083/rcm38956
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of Arrhythmic Mitral Valve Prolapse: Potential Impact and Current Evidence

А. S. Sukhotko, N.V. Pichugina, Serghei Covanţev, Anna Bumbu et al.
Reviews in Cardiovascular Medicine
Cardiac Valve Diseases and Treatments
article

Management of Arrhythmic Mitral Valve Prolapse: Potential Impact and Current Evidence

А. S. Sukhotko, N.V. Pichugina, Serghei Covanţev, Anna Bumbu, Andia Taghdiri
article en

Abstract

Mitral valve prolapse (MVP), also known as floppy mitral valve syndrome, systolic click-murmur syndrome, and billowing mitral leaflets, is a developmental anomaly caused when one or two abnormal valve leaflets are displaced into the left atrium below the mitral valve annulus during systole. MVP is observed in 2-3% of patients in the general population and is the leading cause of mitral regurgitation (MR) in developed countries. Overall, MVP is considered a benign developmental anomaly; however, evidence suggests that MVP is associated with sudden cardiac death. Thus, there have been ongoing discussions about the optimal management of this patient group, which includes both pharmacological treatment and surgical interventions. This review aimed to provide an overview of the benign and arrhythmic MVP (AMVP), its diagnostic options, and management possibilities.

Reviews in Cardiovascular MedicineVol. 26(9)
Tbilisi State University (GE), Botkin Hospital (RU)
Openalex Percentile: Top 56%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.